Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Specialty Chemicals
Clariant to expand mild surfactant production in the US and Europe
by Craig Bettenhausen
May 29, 2020
| A version of this story appeared in
Volume 98, Issue 21
Credit: Clariant
Clariant will expand the capacity of this surfactant plant in Spain.
Clariant plans to expand capacity to make isethionates, mild surfactants used in personal-care applications, at its plants in Mount Holly, North Carolina, and Tarragona, Spain. Isethionates are esters made from 2-hydroxyethanesulfonic acid and long-chain fatty acids, the latter of which are derived from natural sources like animal or vegetable fats. Clariant says the move, to be completed by the first quarter of 2021, reflects increasing customer demand for naturally derived soaps and lotions that are gentle on the skin.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter